BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32501811)

  • 1. miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.
    Li Q; Liu J; Jia Y; Li T; Zhang M
    Aging (Albany NY); 2020 Jun; 12(11):10246-10258. PubMed ID: 32501811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
    Ren F; Su H; Jiang H; Chen Y
    J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN.
    Meng L; Chen Z; Jiang Z; Huang T; Hu J; Luo P; Zhang H; Huang M; Huang L; Chen Y; Lu M; Xu AM; Ying S
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):49-57. PubMed ID: 31828293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer.
    Li L; Wei D; Zhang J; Deng R; Tang J; Su D
    Comput Math Methods Med; 2022; 2022():5203839. PubMed ID: 35069784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
    Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
    Yang S; Li X; Shen W; Hu H; Li C; Han G
    J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183.
    Jin C; Zhao W; Zhang Z; Liu W
    Life Sci; 2020 Jan; 241():117097. PubMed ID: 31760099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F; Zhuang L; Wu R; Li D
    J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.